|
Forest Medical Holter Monitoring Systems Selected for
Marfan Syndrome Clinical Trial
East Syracuse, NY, April 2nd, 2007 — Forest
Medical, LLC (www.forestmedical.com),
the value leader in Holter monitoring systems, today announced that
its Holter Monitoring Systems have been selected for a clinical
trial of the drugs Atenolol versus Losartan in individuals with
Marfan syndrome. Forest Medical will provide 100 Trillium 5000™
Holter Recorders and multiple installations of its Trillium
Platinum™ Holter Analysis Software to support 16 different research
sites for the trial which will be conducted by the Pediatric Heart
Network. The trial is funded by the National Institutes of Health (NIH),
National Heart, Lung and Blood Institute and will involve up to 600
participants who will each be followed for a period of three years.
The trial will study the growth of the aorta in participants taking
either Atenolol (a beta blocker) or Losartan (an angiotensin II
receptor blocker). Mr. Raymond Lichorobiec, the company’s Executive
Director, said “Forest Medical is honored that our Trillium
5000/Platinum Holter Monitoring Systems have been selected by the
Pediatric Heart Network for this important clinical trial.”
The prestigious list of research sites involved in the trial
includes the Hospital for Sick Children (Ontario, Canada),
Children’s Hospital Boston (Boson, MA), Children’s Hospital of New
York (New York, NY), The Children’s Hospital of Philadelphia
(Philadelphia, PA), Duke University Medical Center (Durham, NC),
East Carolina University (Greenville, NC), Brenner Children’s
Hospital at Wake Forest University Baptist Medical Center (Winston
Salem, NC), Medical University of South Carolina (Charleston, SC),
Intermountain Healthcare Primary Children’s Medical Center (Salt
Lake City, UT), Cincinnati Children’s Hospital Medical Center
(Cincinnati, OH), Johns Hopkins Hospital (Baltimore, MD), Washington
University (St. Louis, MO), Texas Children’s Hospital (Houston, TX),
Stanford University Medical Center (Stanford, CA), Ghent University
Hospital (Ghent, Belgium), Division of Pediatric Cardiology Mount
Sinai Medical Center (New York, NY).
About
Pediatric Heart Network
The Pediatric Heart Network (PHN) was established in 2001 by the
National Heart, Lung, and Blood Institute of the National Institutes
of Health (NIH) to improve the outcomes and quality of life in
children who acquire or are born with heart disease. For more
information on the PHN, please visit their web site at
www.pediatricheartnetwork.org. For more information on the
Marfan clinical trial, please select the Marfan link at
www.pediatricheartnetwork.org/currentstudies.asp.
About Forest Medical, LLC
Forest Medical, LLC has been a long term pioneer in the development
of digital Holter monitoring technology and is today’s value leader
in Holter monitoring systems. The company offers a wide range of
Holter monitoring products that are designed to meet the
requirements of the primary care, cardiology, hospital, research,
and veterinary markets and has thousands of systems in use. For more
information, please visit the company’s web site at
www.forestmedical.com or contact Forest Medical, LLC directly at:
800-844-2037 or 315-434-9000.
END |
